SLNSW-Flavonoid Apigenin Is an Inhibitor of the NAD+ase...-TN_cdi_pubmed_primary_23172919

Flavonoid Apigenin Is an Inhibitor of the NAD+ase CD38: Implications for Cellular NAD+ Metabolism, Protein Acetylation, and Treatment of Metabolic Syndrome

Full title: Flavonoid Apigenin Is an Inhibitor of the NAD+ase CD38: Implications for Cellular NAD+ Metabolism, Protein Acetylation, and Treatment of Metabolic Syndrome

Author/creator: ESCANDE, Carlos, NIN, Veronica, PRICE, Nathan L, CAPELLINI, Verena, GOMES, Ana P, BARBOSA, Maria Thereza, O'NEIL, Luke, WHITE, Thomas A, SINCLAIR, David A, CHINI, Eduardo N.

Call Numbers:

Record Identifier: TN_cdi_pubmed_primary_23172919

Language: English

Formats: Articles

Publishers: Alexandria, VA: American Diabetes Association

Permalink: https://collection.sl.nsw.gov.au/record/TN_cdi_pubmed_primary_23172919

Articles

Articles

Export this record

Export selected records

  • Export to excel
  • Permalink

    • Export record to excel

    File type to download

    Beta version

    Record title

    Flavonoid Apigenin Is an Inhibitor of the NAD+ase CD38: Implications for Cellular NAD+ Metabolism, Protein Acetylation, and Treatment of Metabolic Syndrome

    Record identifier

    TN_cdi_pubmed_primary_23172919

    Record permalink

    https://collection.sl.nsw.gov.au/record/TN_cdi_pubmed_primary_23172919

    Share

    Flavonoid Apigenin Is an Inhibitor of the NAD+ase CD38: Implications for Cellular NAD+ Metabolism, Protein Acetylation, and Treatment of Metabolic Syndrome

    ACCESS
    https://collection.sl.nsw.gov.au/record/TN_cdi_pubmed_primary_23172919

    Flavonoid Apigenin Is an Inhibitor of the NAD+ase CD38: Implications for Cellular NAD+ Metabolism, Protein Acetylation, and Treatment of Metabolic Syndrome

    Full title

    Flavonoid Apigenin Is an Inhibitor of the NAD+ase CD38: Implications for Cellular NAD+ Metabolism, Protein Acetylation, and Treatment of Metabolic Syndrome

    Author / Creator

    ESCANDE, Carlos ; NIN, Veronica ; PRICE, Nathan L ; CAPELLINI, Verena ; GOMES, Ana P ; BARBOSA, Maria Thereza ; O'NEIL, Luke ; WHITE, Thomas A ; SINCLAIR, David A ; CHINI, Eduardo N

    Publisher

    Alexandria, VA: American Diabetes Association

    Journal title

    Diabetes (New York, N.Y.), 2013, Vol.62 (4), p.1084-1093

    Record Identifier

    TN_cdi_pubmed_primary_23172919

    Language

    English

    Formats

    Articles

    Publication information

    Publisher

    Subjects

    Subjects and topics

    ADP-ribosyl Cyclase 1 - antagonists & inhibitors ADP-ribosyl Cyclase 1 - metabolism Animals Apigenin - chemistry Apigenin - pharmacology Biological and medical sciences Cell Line, Tumor Diabetes. Impaired glucose tolerance Endocrine pancreas. Apud cells (diseases) Endocrinopathies Etiopathogenesis. Screening. Investigations. Target tissue resistance Gene Expression Regulation - drug effects Humans Medical sciences Metabolic diseases Metabolic Syndrome - drug therapy Mice Mice, Inbred C57BL Mice, Knockout Miscellaneous Molecular Structure NAD - metabolism Obesity - drug therapy Obesity - metabolism Other metabolic disorders Quercetin - chemistry Quercetin - pharmacology Random Allocation Sirtuin 1 - genetics Sirtuin 1 - metabolism

    More information

    — SCOPE AND CONTENTS

    Contents

    — ALTERNATIVE TITLES

    Full title

    — AUTHORS, ARTISTS AND CONTRIBUTORS

    Author / Creator

    Identifiers

    — PRIMARY IDENTIFIERS

    Record Identifier

    TN_cdi_pubmed_primary_23172919

    Permalink

    https://collection.sl.nsw.gov.au/record/TN_cdi_pubmed_primary_23172919

    — OTHER IDENTIFIERS

    ISSN

    E-ISSN

    DOI

    How to access this item

    Online

    1 item

    How to access?

    Login with a Library card

    Full text available >

    About resource >

    About resource >

    View in old catalogue

    Connecting people and collections